Latest Headlines

1. COVID Rapid Test Confirms Presence Of Antibodies 6/18/2021

   A U.S. clinical trial of a COVID-19 rapid test approved by an institutional review board found the Specificity of confirmed negative Covid-19 patients by RT-PCR was 100% (95% CI, 88.4%-100.0%); meaning there was 100% agreement between a negative RT-PCR and negative Clungene® serological test result.

2. PierianDx And Intermountain Healthcare Combine Expertise To Advance Myriad Genetics’ Tumor Test Offering 6/16/2021

   PierianDx, the global leader in clinical genomics knowledge, today announced that it will work with existing partner, Intermountain Healthcare, to support Myriad Genetics’ comprehensive germline and somatic tumor testing service.

3. Molecular Laboratory, Discover Labs, Provides Fast Diagnostic Testing For Clinicians, Physicians, Doctors And Nursing Homes 6/16/2021

   Discover Labs, a full-service, diagnostic laboratory, has announced its launch of fast diagnostic testing for nursing homes, primary care doctors, clinics, and prescribing physicians nationwide.

4. Applied UV Announces Laboratory Results Confirm SteriLumen's Lumicide Ribbon Kills SARS-CoV-2 (COVID-19 Virus) 6/16/2021

   Applied UV, Inc. ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced testing results from an independent third-party laboratory confirming that the SteriLumen Lumicide Ribbon, Applied UV's proprietary connected UVC disinfection platform for surface disinfection, kills SARS-CoV-2 (COVID-19 Virus).

5. Waters Arc Premier System Delivers Increased Precision And Certainty In Chromatographic Results 6/15/2021

   Waters Corporation today introduced the Waters Arc Premier System, the first liquid chromatography system optimized for chromatographic separations on 2.5 – 3.5 micron columns to also feature Waters’ novel MaxPeak High Performance Surface (HPS) technology.

6. Personal Genome Diagnostics Enters Collaborative Partnership With Clinical Molecular Diagnostics Laboratory Of Major University Health System 6/15/2021

   Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced a collaborative partnership with the Duke University Health System (DUHS) Clinical Molecular Diagnostics Laboratory.

7. Biocept Receives More Than 420,000 Samples During First Year Of Offering COVID-19 Testing Service 6/15/2021

   Biocept, Inc., a leading provider of molecular diagnostic assays, products and services, announces that it has received more than 420,000 samples for SARS-CoV-2 testing since launching this service in June 2020.

8. Cherry Picking 2D Barcoded Sample Tubes 6/15/2021

   Ziath has posted a new video that shows how its Mohawk semi-automated tube selector is a productive and versatile tool for cherry picking tubes from multiple racks.

9. Enzo Biochem Announces Online Service With TrustAssure To Schedule Timely PCR Testing Required For International Travel 6/15/2021

   Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, and CLX Health, developer of cloud-based solutions to manage the COVID-19 testing ecosystem through its TrustAssure™ Global Network, today announced a new collaboration to provide rapid access in New York and New Jersey to COVID-19 PCR testing that will be required for international travel from the U.S. to destinations around the world.

10. Quidel Receives Amended Emergency Use Authorization For New Sofia Q Rapid Antigen Test Device 6/11/2021

    Quidel Corporation (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has received an amended Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) allowing the company to market Sofia Q, its latest addition to the Sofia and Sofia 2 line of Fluorescent Immunoassay Analyzers (FIA). Sofia Q features a sleek, miniaturized design that reads the same Sofia SARS.